BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 30046007)

  • 41. Oral health and human papillomavirus-associated head and neck squamous cell carcinoma.
    Mazul AL; Taylor JM; Divaris K; Weissler MC; Brennan P; Anantharaman D; Abedi-Ardekani B; Olshan AF; Zevallos JP
    Cancer; 2017 Jan; 123(1):71-80. PubMed ID: 27571516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The microbiome of HPV-positive tonsil squamous cell carcinoma and neck metastasis.
    Rajasekaran K; Carey RM; Lin X; Seckar TD; Wei Z; Chorath K; Newman JG; O'Malley BW; Weinstein GS; Feldman MD; Robertson E
    Oral Oncol; 2021 Jun; 117():105305. PubMed ID: 33905914
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Subtypes of HPV-Positive Head and Neck Cancers Are Associated with HPV Characteristics, Copy Number Alterations, PIK3CA Mutation, and Pathway Signatures.
    Zhang Y; Koneva LA; Virani S; Arthur AE; Virani A; Hall PB; Warden CD; Carey TE; Chepeha DB; Prince ME; McHugh JB; Wolf GT; Rozek LS; Sartor MA
    Clin Cancer Res; 2016 Sep; 22(18):4735-45. PubMed ID: 27091409
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of human papillomavirus on the clinical presentation of oropharyngeal carcinoma in the United States.
    Stenmark MH; Shumway D; Guo C; Vainshtein J; Mierzwa M; Jagsi R; Griggs JJ; Banerjee M
    Laryngoscope; 2017 Oct; 127(10):2270-2278. PubMed ID: 28304083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low prevalence of human papillomavirus in oral cavity carcinomas.
    Machado J; Reis PP; Zhang T; Simpson C; Xu W; Perez-Ordonez B; Goldstein DP; Brown DH; Gilbert RW; Gullane PJ; Irish JC; Kamel-Reid S
    Head Neck Oncol; 2010 Mar; 2():6. PubMed ID: 20226055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Primary surgery results in no survival benefit compared to primary radiation for oropharyngeal cancer patients stratified by high-risk human papilloma virus status.
    Lybak S; Ljøkjel B; Haave H; Karlsdottir À; Vintermyr OK; Aarstad HJ
    Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):477-487. PubMed ID: 27491318
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma.
    Sano D; Oridate N
    Int J Clin Oncol; 2016 Oct; 21(5):819-826. PubMed ID: 27339270
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
    Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH
    Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Role of Human Papillomavirus in Oropharyngeal Squamous Cell Carcinoma.
    Ducatman BS
    Arch Pathol Lab Med; 2018 Jun; 142(6):715-718. PubMed ID: 29848036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HPV-associated neuroendocrine carcinoma of the oropharynx: a rare new entity with potentially aggressive clinical behavior.
    Kraft S; Faquin WC; Krane JF
    Am J Surg Pathol; 2012 Mar; 36(3):321-30. PubMed ID: 22301491
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mate pair sequencing of oropharyngeal squamous cell carcinomas reveals that HPV integration occurs much less frequently than in cervical cancer.
    Gao G; Johnson SH; Kasperbauer JL; Eckloff BW; Tombers NM; Vasmatzis G; Smith DI
    J Clin Virol; 2014 Mar; 59(3):195-200. PubMed ID: 24440282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differences in the viral genome between HPV-positive cervical and oropharyngeal cancer.
    LeConte BA; Szaniszlo P; Fennewald SM; Lou DI; Qiu S; Chen NW; Lee JH; Resto VA
    PLoS One; 2018; 13(8):e0203403. PubMed ID: 30161236
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genomic characterization of clonal evolution during oropharyngeal carcinogenesis driven by human papillomavirus 16.
    Chae J; Park WS; Kim MJ; Jang SS; Hong D; Ryu J; Ryu CH; Kim JH; Choi MK; Cho KH; Moon SH; Yun T; Kim JI; Jung YS
    BMB Rep; 2018 Nov; 51(11):584-589. PubMed ID: 29936930
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epigenetic Mechanisms of Human Papillomavirus-Associated Head and Neck Cancer.
    Anayannis NV; Schlecht NF; Belbin TJ
    Arch Pathol Lab Med; 2015 Nov; 139(11):1373-8. PubMed ID: 25978766
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HPV16 increases the number of migratory cancer stem cells and modulates their miRNA expression profile in oropharyngeal cancer.
    Hufbauer M; Maltseva M; Meinrath J; Lechner A; Beutner D; Huebbers CU; Akgül B
    Int J Cancer; 2018 Sep; 143(6):1426-1439. PubMed ID: 29663357
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative molecular profiling of HPV-induced squamous cell carcinomas.
    Koncar RF; Feldman R; Bahassi EM; Hashemi Sadraei N
    Cancer Med; 2017 Jul; 6(7):1673-1685. PubMed ID: 28556593
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human papilloma virus status evaluation and survival description in selected oropharyngeal and laryngeal squamous cell carcinoma patients from Hungary.
    Reka Fejer E; Abram Z; Zs Egyed J; Voidazan S; Toth E; Szentirmay Z; Kasler M
    J BUON; 2016; 21(1):168-74. PubMed ID: 27061545
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical relevance of copy number profiling in oral and oropharyngeal squamous cell carcinoma.
    van Kempen PM; Noorlag R; Braunius WW; Moelans CB; Rifi W; Savola S; Koole R; Grolman W; van Es RJ; Willems SM
    Cancer Med; 2015 Oct; 4(10):1525-35. PubMed ID: 26194878
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
    Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
    Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.